Abstract
Chronic alcohol consumption increases the risk of hepatocellular carcinoma (HCC). However, little is known about the potential immunological mechanisms by which ethanol affects tumor progression. Here, adult male mice were administered multiple doses of diethylnitrosamine (DEN). Four and a half months later, the DEN-treated mice were placed on a liquid Lieber-DeCarli control diet or diet containing 5% ethanol for 2.5 months. At the end of the study, liver tissue samples were obtained to analyze pathology, gene expression, and hepatic mononuclear cells (MNCs). Results showed that ethanol feeding exacerbates the progression of hepatic tumors (characterized by the ratio of liver weight to body weight, and the tumor volume and diameter) in DEN-treated mice. Mechanistically, chronic alcohol consumption decreased the number of antitumor CD8+ T cells but increased the number of tumor-associated macrophages (TAMs) in the liver in DEN-initiated tumorigenesis. Besides, TAMs were prone to be M2 phenotype after alcohol consumption. Moreover, chronic alcohol consumption aggravated inflammation, fibrosis, and epithelial-mesenchymal transition (EMT) in the pathological process of HCC. These data demonstrate that chronic alcohol consumption exacerbates DEN-induced hepatocarcinogenesis by enhancing protumor immunity, impairing antitumor immunity and aggravating hepatic pathological injury. Targeting the immune system is a potential therapeutic regimen for alcohol-promoted HCC.
Similar content being viewed by others
Introduction
Hepatocellular carcinoma (HCC) is a primary hepatic malignancy, the third leading cause of cancer-related deaths and the fifth most common tumor worldwide. HCC predominantly occurs in the context of chronic liver disease, which is usually contributed by hepatitis B or hepatitis C infection and chronic alcohol consumption. The highest incidence rates of HCC have been reported in East Asia, particularly in China, where people are susceptible to HBV infection1. Epidemiology has characterized alcoholic liver disease (ALD)-associated cirrhosis as a medium-high risk factor for HCC2.
The establishment of HCC is a multistage process that involves inflammation, cirrhosis, and epithelial-mesenchymal transition (EMT). Alcohol abuse and chronic HBV or HCV infection leads to chronic hepatitis accompanied by inflammation, oxidative stress, and metabolic disorders. Over time, hypoxia, genetic instability, and immune evasion become key features of the liver microenvironment. In general terms, patients with chronic hepatitis develop fibrosis and cirrhosis and then HCC; however, certain patients are at high risk of developing HCC in the absence of advanced cirrhosis3. Chronic alcohol consumption leads to ALD, including steatosis, alcoholic steatohepatitis, and cirrhosis4. Chronic alcohol consumption contributes to the occurrence of HCC through metabolic disorders, such as acetaldehyde formation, reduced antioxidants, hypomethylation, iron overload, and reduced retinoic acid5. However, the existing evidence of the effect of chronic alcohol consumption on HCC development using different models is contradictory6,7,8,9.
The liver is increasingly regarded as an immunological organ and is enriched in Kupffer cells, γδ T cells, natural killer (NK) cells, and natural killer T (NKT) cells10. Immune cells exert immunosurveillance in the early stages by removing premalignant and fully transformed cells. Immunosurveillance depends on NK cells, CD8+ cytotoxic T cells (CTLs), and various cytokines11. In the advanced stages, tumor-associated macrophages (TAMs), myeloid-derived suppressor cells, and regulatory T cells exert immunosuppressive capabilities, inducing angiogenesis and even metastasis12. Chronic alcohol consumption influences immune cells in the liver, such as Kupffer cell activation13, iNKT cell accumulation14, 15, neutrophil infiltration15, 16, inhibition of NK cell activity17, and dendritic cell (DC) function18. Moreover, chronic alcohol consumption can also induce altered expression of hepatic cytokines, including IL-1β, IL-6, IL-10, TNF-α, and IL-2214, 19, 20. HCC is a typical inflammation-induced cancer. Clinical studies have reported higher expression of IL-1β, IL-6, IL-10, and IL-22 in HCC patients, thus promoting HCC21,22,23. Given that immune cells play key roles in HCC development, the effect of chronic alcohol consumption on hepatic immune status during HCC has not been well described. In addition, the immune mechanisms by which alcohol consumption modulates HCC progression remain unclear.
In our mouse alcohol-DEN-HCC model, chronic alcohol consumption exacerbated inflammation and fibrosis and promoted EMT and HCC. Moreover, Chronic alcohol consumption decreased levels of antitumor CD8+ T cells but increased TAMs. Our data show that ethanol consumption alters intrahepatic immune microenvironment and pathological management, thereby affecting HCC development.
Results
Chronic alcohol consumption promotes DEN-initiated tumorigenesis
To study the effect of chronic alcohol consumption on tumor progression, the procedure was performed as described (Supplemental Fig. S1). The mice fed alcohol for 2.5 months exhibited more HCCs per liver than did the pair-fed mice (Fig. 1a). Moreover, alcohol consumption significantly increased the liver/body weight ratios (Fig. 1b), tumor volume (Fig. 1c), and tumor maximum diameter (Fig. 1d). Alcohol consumption markedly promoted the expression of Bcl-xl (Fig. 1e) and PCNA (Fig. 1f,g) in the DEN-treated livers. These data suggest that chronic alcohol consumption promotes DEN-initiated tumorigenesis.
Chronic alcohol consumption increases tumor-associated macrophage infiltration
Hepatocarcinogenesis is a multifactorial and dynamic event that involves inflammation, fibrosis, and epithelial-mesenchymal transition (EMT), in which immune cells and immune factors are known to play important roles. Therefore, we examined the changes of immune status induced by chronic alcohol consumption in the DEN-treated liver. Firstly, the frequency and number of macrophages in the liver were higher in the DEN + E diet group than those in the DEN + C diet group (Fig. 2a,b). In accordance, higher mRNA expression of CCL2 were found in the DEN + E diet group (Fig. 2c), which could recruit monocytes into the liver. Moreover, Hepatic CD206 expression was elevated in the DEN + E group (Fig. 2d). This indicated that macrophages after chronic alcohol consumption were prone to be alternatively activated M2 macrophages. As expected, the expression of M2-polarization factors IL-4 and IL-10 dramatically increased in the DEN + E group (Fig. 2e), whereas M1-polarization factor IL-12 expression was lower in the DEN + E group (Fig. 2f). Besides, M2-associated protumor genes in the liver were elevated after chronic alcohol consumption, including TGF-beta, CXCL2 and CCL22 (Fig. 2g). These data indicate that chronic alcohol consumption promotes the accumulation of macrophages into the liver and M2 polarization.
Chronic alcohol consumption reduces antitumor CD8+ T cells
The roles of chronic alcohol consumption in antitumor immunity were also explored after accessing the protumor immunity. CD8+ T cells and NK cells are essential antitumor immune cells. As shown in Fig. 3, chronic alcohol consumption decreased the frequency and number of CD8+ T cells in the DEN-treated liver (Fig. 3a–c). However, chronic alcohol consumption had no effect on the frequency and number of NK cells in the liver (data not shown). These data suggest that chronic alcohol consumption weakens antitumor immunity in DEN-initiated tumorigenesis.
Chronic alcohol consumption aggravates inflammation
Given that HCC is a typical inflammation-related tumor, we wondered whether chronic alcohol consumption would exacerbate hepatic inflammation. Compared with the pair-fed mice in the DEN + C group, the mice in the DEN + E group exhibited significantly higher ALT (Fig. 4a) and TG levels (Fig. 4b) and displayed more fat vacuoles in the liver (Fig. 4c), indicating more severe liver damage and pan-lobular steatosis in the DEN + E group. Besides, as shown in Fig. 4d, the hepatic mRNA levels of HCC-promoting inflammatory factors, including IL-6 and IL-17A were markedly increased in the DEN + E group compared with the pair-fed group. These data suggest that chronic alcohol consumption aggravated inflammation level in the process of DEN-induced hepatocarcinogenesis.
Chronic alcohol consumption exacerbates fibrosis and promotes EMT
Human HCCs occur primarily in the setting of clinical fibrosis or cirrhosis. Considering the worse steatohepatitis in the DEN + E group, we wondered whether chronic alcohol consumption played a role in hepatic fibrosis. Notably, compared with pair-fed mice in the DEN + C group, mice in the DEN + E group showed more fibrous septa in liver sections, as visualized by Sirius red staining (Fig. 5a). Moreover, the mRNA expression of the fibrosis-related genes Col1A1, MMP2, and TIMP1 in the liver were higher in the DEN + E group than in the DEN + C group (Fig. 5b). Activated hepatic stellate cells (HSCs) are the main collagen-producing cells in liver fibrosis24. α-SMA and GFAP are markers of HSC activation24, 25. The levels of α-SMA and GFAP were markedly greater in the DEN + E group compared to the DEN + C group (Fig. 5c). In addition, EMT is increasingly recognized as a crucial driver of cell plasticity and contributes to therapeutic resistance, tumor recurrence, and metastatic progression26. Chronic alcohol consumption significantly increased the expression of the EMT-related genes snail, E-cadherin, and MMP9 in the livers of the DEN + E group (Fig. 5d). These data suggest that chronic alcohol consumption promotes liver fibrosis and EMT in the process of hepatocarcinogenesis.
Discussion
Alcohol abuse is a significant risk factor for liver diseases, owing to changes in lifestyle, regardless of other factors. Epidemiological data have suggested that alcohol abuse contributes to HCC development1, 2. In the current study, we demonstrated that alcohol promotes HCC progress in mice via increasing tumor-associated macrophage infiltration, reducing antitumor CD8+ T cells, exacerbating fibrosis, and promoting EMT (Fig. 6).
The effects of chronic alcohol consumption on HCC progression vary in different animal models. In accordance with Elizabeth Brandon-Warner and Aditya Ambade’s studies8, 9, chronic alcohol consumption promoted DEN-induced HCC progression in our model. However, Maotai liquor ameliorates DEN-induced hepatocarcinogenesis7. The factors contributing to these contradictory outcomes are likely to be complex and to include factors such as the carcinogen class (chemical or biological), time and dose of DEN injection, ethanol category, ethanol feeding concentration, and duration.
The tumor milieu contains many macrophages, which are extremely heterogeneous and are divided systematically into two main classes resembling the Th1/Th2 dichotomy27. Chemokines are crucial factors for monocytes migration into local tissue. Chronic alcohol consumption increased hepatic CCL2 expression, which promote macrophages accumulation into the liver28. TAMs tend to have a protumor M2-like phenotype. Alcohol abuse increases IL-4 and IL-10 levels as well as TGF-beta expression in the liver, thus inducing alternatively activated M2 macrophages. Moreover, CD206, a marker for M2 macrophages, also showed a higher expression level in the DEN + E group, consistent with findings from a recent report8. This information indicated that chronic alcohol abuse promotes a shift to M2 macrophages.
CD8+ T cells are primary antitumor immune cells. Data have confirmed that the numbers and activity of CD8+ T cells decrease in the advanced tumor microenvironment29. The numbers of CD8+ T cells in the liver after chronic alcohol consumption were significantly reduced in DEN-initiated hepatocarcinogenesis. The study from the comparison between patients with alcoholic cirrhosis and a healthy control identifies that ethanol could induce the apoptosis of CD8+ T cells30. Ethanol-induced apoptosis and higher TGF-β levels may count for CD8+ T cells decrease after chronic alcohol consumption in DEN-initiated hepatocarcinogenesis.
HCC is a typical inflammation-associated cancer. Chronic alcohol consumption leads to higher inflammation level in DEN-treated livers. IL-6 and IL-17A were up-regulated in DEN + E group, which are proved to promote HCC progression31, 32. Liver fibrosis is a consequence of the wound-healing response to virtually all forms of chronic liver injury. EMT involves modifying the adhesion molecules expressed by the cell, thus causing cells to obtain migratory and invasive abilities, and it is a significant driver during tumor progression33. Herein, we found that the markers of fibrosis and EMT in the DEN + E group showed higher expression than did the DEN + C group. TGF-β signaling has been shown to play an important role in fibrosis and EMT34, 35. As shown in Fig. 2. G, hepatic TGF-β expression was observably up-regulated after chronic alcohol consumption. These data suggest that chronic alcohol consumption activates fibrosis and EMT signaling via TGF-β in the liver, thereby contributing to HCC progression.
In summary, alcohol consumption promotes the development of HCC. Our data suggest that immune elements, including CD8+ T cells, macrophages as well as chemokines and cytokines, are changed by alcohol and are involved in the pathology of chronic alcohol consumption, promoting HCC in a DEN-initiated HCC mouse model. Future studies and clinical research should focus on immune cells, cytokines, and chemokines in hepatocarcinogenesis in the context of chronic alcohol consumption.
Methods
Materials
Diethylnitrosamine (DEN) was purchased from Sigma-Aldrich (St. Louis, MO). Ethanol was purchased from Sinopharm (Shanghai, China). An assay kit to measure alanine aminotransferase (ALT) was purchased from Rong Sheng (Shanghai, China). An assay kit to test triglyceride (TG) levels was purchased from Changchun Huili (Jilin, China). TRIzol reagent was purchased from Invitrogen (Carlsbad, CA). Antibodies against mouse proliferating cell nuclear antigen (PCNA) (ZSGB-BIO, China) were purchased for immunohistochemistry analysis.
Animal Assurances
Male C57BL/6 mice (6–8 weeks old) were purchased from the Shanghai Laboratory Animal Center at the Chinese Academy of Sciences (Shanghai, China). All mice were maintained in specific-pathogen-free and temperature-controlled microisolator cages with a 12-h light/dark cycle. All the procedures regarding animal handling were performed in accordance with the animal care regulations of the University of Science and Technology of China. All the animal experiment protocols were approved by the Local Ethics Committee for Animal Care and Use at University of Science and Technology of China.
Animal Experiments
Mice (approximately 2 months old) were weighed and injected with DEN (40 mg/kg body weight [BW] intraperitoneally [i.p.]) dissolved in saline every 4 days for a total of 10 times. Then, mice (approximately 6.5 months old) were randomly divided into two groups (Supporting Information Fig. 1A): ethanol groups were fed a liquid diet containing 5% ethanol (TROPHIC, Nantong, China) for 2.5 months, whereas control groups were pair-fed a control diet (TROPHIC, Nantong, China) for 2.5 months.
Mice were weighed and sacrificed after 7 months of DEN treatment. Livers were excised, weighed, and examined for visible lesions, and representative liver tissues (5 to 7 mm) were taken from the same lobes. Tissue samples were either snap frozen in liquid nitrogen and stored prior to analysis or fixed in 12% neutral and acidic buffered formalin (at least 36 hours) prior to histological processing. The remaining liver tissue samples were used for isolating liver mononuclear cells (MNCs).
Alanine Liver Transaminase Activity and Triglyceride Content Analysis
Serum alanine aminotransferase (ALT) was detected using an automated Chemray 240 clinical analyzer (Rayto, Shenzhen, China). Total hepatic lipid extraction was performed according to the operation manual. The TG content was tested using a commercial diagnostic kit (Changchun Huili, Jilin, China).
Hematoxylin & Eosin (H&E) and Picrosirius Red Staining
For histological analysis, liver tissues were fixed in 12% acidic buffered formalin, and paraffin-embedded liver samples were sliced into 6-µm-thick sections, deparaffinized, dehydrated, and stained with H&E. For fibrosis analysis, liver tissues were fixed in 12% neutral buffered formalin and embedded in paraffin. Tissues were affixed to slides, deparaffinized, and stained with Sirius red (0.1%). All the slices described above were examined under light microscopy.
Immunohistochemical Staining
Liver tissues were fixed in 12% neutral buffered formalin to observe liver slides. For PCNA staining, liver slides were stained with a 1:100 dilution of an anti-PCNA (ZSGB-BIO, Beijing, China) primary antibody overnight, and this was followed by a polymer HRP detection system (ZSGB-BIO, Beijing, China). Brown stains were developed using a 3,3-diaminobenzidine kit (Vector Laboratories, Burlingame, CA).
RNA Isolation and Quantitative RT-PCR (Q-PCR)
Total RNA was extracted from liver tissue using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. cDNA was synthesized from random hexamers and reverse-transcribed using commercial reverse-transcription kits (Invitrogen). Gene expression levels were measured with Q-PCR using the commercially available SYBR Premix ExTaq (TaKaRa Biotechnology, Dalian, China) in a Corbett Rotor-Gene 3000 real-time PCR system (Corbett Research) according to the manufacturer’s instructions. Data were analyzed using the △△Ct method as previously described36. Fold changes in gene expression were calculated relative to the housekeeping gene beta-actin. The primer sequences are provided in Table S1.
Liver Mononuclear Cell Isolation
Liver MNCs were isolated as previously described. Briefly, livers were passed through a 200-gauge stainless steel mesh. Cells were resuspended in 42% Percoll (Gibco BRL) and then centrifuged at 1260 g for 30 min at room temperature. The pellets were resuspended with red blood cell lysis buffer and washed with PBS. MNCs were used for cellularity and flow cytometric (FCM) analyses.
Flow Cytometry and Antibody Staining
The fluorescence-labeled monoclonal antibodies were as follows: FITC-anti-CD3, PerCp-Cy5.5-anti-CD8, APC-Cy7-anti-CD11b, PerCp-Cy5.5-anti-F4/80, APC-anti-CD4, and PE-Cy7-anti-CD45 were purchased from Biolegend (San Diego, CA, USA); FITC-anti-CD11b was from BD Biosciences (San Jose, CA, USA); and PerCp-Cy5.5-anti-F4/80 was from eBioscience (San Diego, CA, USA). MNCs were stained with the indicated antibodies as previously described37. Data were collected on a FACSCalibur flow cytometer (BD Biosciences) and analyzed using FlowJo 7.6.1 (Tree Star, Ashland, OR).
Statistical Analysis
All data were analyzed using Student’s t test and are expressed as the means ± standard error of the mean (SEM). P < 0.05 was considered statistically significant. Calculations were made by using GraphPad Prism version 6.0 (GraphPad Software, Inc., San Diego, CA).
References
El-Serag, H. B. & Rudolph, K. L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557–2576, doi:10.1053/j.gastro.2007.04.061 (2007).
Joshi, K., Kohli, A., Manch, R. & Gish, R. Alcoholic Liver Disease: High Risk or Low Risk for Developing Hepatocellular Carcinoma? Clinics in liver disease 20, 563–580, doi:10.1016/j.cld.2016.02.012 (2016).
Goossens, N. & Hoshida, Y. Hepatitis C virus-induced hepatocellular carcinoma. Clinical and molecular hepatology 21, 105–114, doi:10.3350/cmh.2015.21.2.105 (2015).
Gao, B. & Bataller, R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141, 1572–1585, doi:10.1053/j.gastro.2011.09.002 (2011).
Sidharthan, S. & Kottilil, S. Mechanisms of alcohol-induced hepatocellular carcinoma. Hepatology international 8, 452–457, doi:10.1007/s12072-013-9494-4 (2014).
Thompson, K. J., Swan, R. Z., Iannitti, D. A., McKillop, I. H. & Sindram, D. Diet-induced obesity and ethanol impair progression of hepatocellular carcinoma in a mouse mesenteric vein injection model. Surgical endoscopy 27, 246–255, doi:10.1007/s00464-012-2429-7 (2013).
Yi, X., Long, L., Yang, C., Lu, Y. & Cheng, M. Maotai ameliorates diethylnitrosamine-initiated hepatocellular carcinoma formation in mice. PloS one 9, e93599, doi:10.1371/journal.pone.0093599 (2014).
Ambade, A., Satishchandran, A., Gyongyosi, B., Lowe, P. & Szabo, G. Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease. World journal of gastroenterology 22, 4091–4108, doi:10.3748/wjg.v22.i16.4091 (2016).
Brandon-Warner, E., Walling, T. L., Schrum, L. W. & McKillop, I. H. Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis. Alcoholism, clinical and experimental research 36, 641–653, doi:10.1111/j.1530-0277.2011.01660.x (2012).
Robinson, M. W., Harmon, C. & O’Farrelly, C. Liver immunology and its role in inflammation and homeostasis. Cellular & molecular immunology 13, 267–276, doi:10.1038/cmi.2016.3 (2016).
Zhang, Q.-F. et al. Liver-infiltrating CD11b−CD27− NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression. Cellular & molecular immunology, doi:10.1038/cmi.2016.28 (2016).
Sachdeva, M., Chawla, Y. K. & Arora, S. K. Immunology of hepatocellular carcinoma. World journal of hepatology 7, 2080–2090, doi:10.4254/wjh.v7.i17.2080 (2015).
Suraweera, D. B., Weeratunga, A. N., Hu, R. W., Pandol, S. J. & Hu, R. Alcoholic hepatitis: The pivotal role of Kupffer cells. World journal of gastrointestinal pathophysiology 6, 90–98, doi:10.4291/wjgp.v6.i4.90 (2015).
Cui, K. et al. Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1beta in mice. Journal of hepatology 62, 1311–1318, doi:10.1016/j.jhep.2014.12.027 (2015).
Mathews, S. et al. Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration. Cellular & molecular immunology 13, 206–216, doi:10.1038/cmi.2015.06 (2016).
Bertola, A., Park, O. & Gao, B. Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin. Hepatology 58, 1814–1823, doi:10.1002/hep.26419 (2013).
Boyadjieva, N., Dokur, M., Advis, J. P., Meadows, G. G. & Sarkar, D. K. Chronic Ethanol Inhibits NK Cell Cytolytic Activity: Role of Opioid Peptide -Endorphin. The Journal of Immunology 167, 5645–5652, doi:10.4049/jimmunol.167.10.5645 (2001).
Feng, D., Eken, A., Ortiz, V. & Wands, J. R. Chronic alcohol-induced liver disease inhibits dendritic cell function. Liver international: official journal of the International Association for the Study of the Liver 31, 950–963, doi:10.1111/j.1478-3231.2011.02514.x (2011).
An, L., Wang, X. & Cederbaum, A. I. Cytokines in alcoholic liver disease. Archives of toxicology 86, 1337–1348, doi:10.1007/s00204-012-0814-6 (2012).
Gao, B. Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease. Journal of gastroenterology and hepatology 27(Suppl 2), 89–93, doi:10.1111/j.1440-1746.2011.07003.x (2012).
Jiang, R. et al. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology 54, 900–909, doi:10.1002/hep.24486 (2011).
Othman, M. S., Aref, A. M., Mohamed, A. A. & Ibrahim, W. A. Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients. ISRN hepatology 2013, 412317, doi:10.1155/2013/412317 (2013).
Su, B. et al. Interleukin-1β/Iinterleukin-1 receptor-associated kinase 1 inflammatory signaling contributes to persistent Gankyrin activation during hepatocarcinogenesis. Hepatology 61, 585–597 (2015).
Tacke, F. & Weiskirchen, R. Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques. Expert review of gastroenterology & hepatology 6, 67–80, doi:10.1586/egh.11.92 (2012).
Tan, Z. et al. Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells. Cellular & molecular immunology, doi:10.1038/cmi.2016.63 (2017).
Polyak, K. & Weinberg, R. A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature reviews. Cancer 9, 265–273, doi:10.1038/nrc2620 (2009).
Sica, A., Erreni, M., Allavena, P. & Porta, C. Macrophage polarization in pathology. Cellular and molecular life sciences: CMLS 72, 4111–4126, doi:10.1007/s00018-015-1995-y (2015).
Ju, C. & Tacke, F. Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies. Cellular & molecular immunology 13, 316–327, doi:10.1038/cmi.2015.104 (2016).
Wherry, E. J. T cell exhaustion. Nature immunology 131, 492–499, doi:10.1038/ni.2035 (2011).
Szuster-Ciesielska, A., Daniluk, J. & Bojarska-Junak, A. Apoptosis of blood mononuclear cells in alcoholic liver cirrhosis. The influence of in vitro ethanol treatment and zinc supplementation. Toxicology 212, 124–134, doi:10.1016/j.tox.2005.04.009 (2005).
Park, E. J. et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140, 197–208, doi:10.1016/j.cell.2009.12.052 (2010).
Gu, F. M. et al. IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma. Molecular cancer 10, 150, doi:10.1186/1476-4598-10-150 (2011).
Nieto, M. A., Huang, R. Y., Jackson, R. A. & Thiery, J. P. Emt: 2016. Cell 166, 21–45, doi:10.1016/j.cell.2016.06.028 (2016).
Xu, F., Liu, C., Zhou, D. & Zhang, L. TGF-beta/SMAD Pathway and Its Regulation in Hepatic Fibrosis. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society 64, 157–167, doi:10.1369/0022155415627681 (2016).
Xu, J., Lamouille, S. & Derynck, R. TGF-beta-induced epithelial to mesenchymal transition. Cell research 19, 156–172, doi:10.1038/cr.2009.5 (2009).
Witting, S. R., Brown, M., Saxena, R., Nabinger, S. & Morral, N. Helper-dependent adenovirus-mediated short hairpin RNA expression in the liver activates the interferon response. The Journal of biological chemistry 283, 2120–2128, doi:10.1074/jbc.M704178200 (2008).
Hou, X., Zhou, R., Wei, H., Sun, R. & Tian, Z. NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis. Hepatology 49, 940–949, doi:10.1002/hep.22725 (2009).
Acknowledgements
This work was supported by the Natural Science Foundation of China (#91429303, 81571610) and the Ministry of Science & Technology of China (973 Basic Science Project 2013CB530506).
Author information
Authors and Affiliations
Contributions
G.X.Y. performed the experiments, analyzed data and wrote the manuscript. R.S. and X.F.W. conceived and designed the experiments, edited the manuscript and discussed the data. C.S. helped analyze data and design the experiments. X.D.Z., H.M.W. and Z.G.T. helped the discussion.
Corresponding authors
Ethics declarations
Competing Interests
The authors declare that they have no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yan, G., Wang, X., Sun, C. et al. Chronic Alcohol Consumption Promotes Diethylnitrosamine-Induced Hepatocarcinogenesis via Immune Disturbances. Sci Rep 7, 2567 (2017). https://doi.org/10.1038/s41598-017-02887-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-017-02887-7
This article is cited by
-
EMT and Inflammation: Crossroads in HCC
Journal of Gastrointestinal Cancer (2023)
-
Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis
Journal of Cancer Research and Clinical Oncology (2023)
-
GSTM1 and GSTT1 null genotype increase the risk of hepatocellular carcinoma: evidence based on 46 studies
Cancer Cell International (2019)
-
Alcoholic liver disease
Nature Reviews Disease Primers (2018)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.